YouTube video by Harun Tulunay

Objectives Long-acting cabotegravir plus rilpivirine (CAB+RPV) offers an alternative to daily oral therapy, but real-world data in East Asia remain scarce. This study aims to evaluate the impact of ...

A survey to understand the breadth and scale of issues which may impact equitable implementation of CAB-LA outside of sexual health clinics in the UK.

PLOS Global Public Health was a natural home for our study due to its commitment to open-access publishing and its focus on amplifying research from diverse and resource-limited settings. Given the gl...

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 8-14 February and includes updates on STI cases, chikungunya, Ebola, measles, avian influenza A (H9N2, H5N1), swine ...

In May 2022, the most widespread outbreak of sustained transmission of mpox outside of countries historically affected countries in Western and Central Africa occurred. We aimed to examine the persona...

PEPFAR’s computer systems also are being taken offline, a sign that the program may not return, as Republican critics had hoped.

Background Tecovirimat, an antiviral treatment for smallpox, was approved as a treatment for mpox by the European Medicines Agency in January 2022. Approval was granted under “exceptional circumstance...

Results of this cohort study support starting tecovirimat in all PWH as soon as an mpox diagnosis is suspected. Additional research is warranted to confirm these findings.